About Aurum Institute Tembisa
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Aurum Institute Tembisa
During the past decade, Aurum Institute Tembisa conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2014-10-28
2017-07-10
Completed
746
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2017-12-05
2020-10-06
Terminated
279
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-04-04
2021-07-01
Completed
366
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
2018-07-17
2020-08-18
Terminated
34
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Aurum Institute Tembisa"
#1 collaborator was "Aurum Institute" with 1 trials as a collaborator, "COVID -19 Therapeutics Accelerator" with 1 trials as a collaborator, "National Institute for Medical Research, Tanzania" with 1 trials as a collaborator, "Oslo University Hospital" with 1 trials as a collaborator and "South African Tuberculosis Vaccine Initiative" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Aurum Institute Tembisa
According to Clinical.Site data, the most researched conditions in "Aurum Institute Tembisa" are
"COVID 19" (1 trials) and "Tuberculosis Infection" (1 trials). Many other conditions were trialed in "Aurum Institute Tembisa" in a lesser frequency.
Clinical Trials Intervention Types at Aurum Institute Tembisa
Most popular intervention types in "Aurum Institute Tembisa" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "H56:IC31" (1 trials) and "MR or M-M-R II ® vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Aurum Institute Tembisa
The vast majority of trials in "Aurum Institute Tembisa" are
2 trials for "All" genders.
Clinical Trials Status at Aurum Institute Tembisa
Currently, there are NaN active trials in "Aurum Institute Tembisa".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Aurum Institute Tembisa,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Aurum Institute Tembisa, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".